The Oncology Service – Richmond
  • Phone: 804-999-0001
  • Our Services
    • Medical Oncology
    • Radiation Oncology
    • Stereotactic Radiation Therapy
    • Diagnostic Imaging
  • For Your Pet
    • Client Registration Form
    • COVID Curb-Side Procedures
    • When Your Pet is a Patient
    • Your First Visit
    • Client Portal
    • FAQ
    • Pet Insurance
    • Grief Resources
    • Clinical Studies
  • For Veterinary Teams
    • COVID-19 Hospital Updates
    • Referral Forms and Portal
    • Continuing Education
    • Clinical Studies
  • About Us
    • Our Hospital
    • Our Team
    • Why Ethos
    • Contact Us
  • Blogs & Videos
    • Our Blogs
  • We’re Hiring!
    • Apply Today
    • Benefits and Perks
    • VetBloom
    • Continuing Education
The Oncology Service – Richmond
  • Our Services
    • Medical Oncology
    • Radiation Oncology
    • Stereotactic Radiation Therapy
    • Diagnostic Imaging
  • For Your Pet
    • Client Registration Form
    • COVID Curb-Side Procedures
    • When Your Pet is a Patient
    • Your First Visit
    • Client Portal
    • FAQ
    • Pet Insurance
    • Grief Resources
    • Clinical Studies
  • For Veterinary Teams
    • COVID-19 Hospital Updates
    • Referral Forms and Portal
    • Continuing Education
    • Clinical Studies
  • About Us
    • Our Hospital
    • Our Team
    • Why Ethos
    • Contact Us
  • Blogs & Videos
    • Our Blogs
  • We’re Hiring!
    • Apply Today
    • Benefits and Perks
    • VetBloom
    • Continuing Education
  • Phone: 804-999-0001

Clinical Studies

  • Ethos Precision Medicine Umbrella Study for Hemangiosarcoma (Ethos-PUSH)

    Currently Enrolling

    Ethos Discovery now seeks to deliver a highly advanced clinical trial program investigating the use of novel drugs for the treatment of Hemangiosarcoma (HSA) with the goal of curing this aggressive cancer. This study will ask if drugs specifically matched to the genomic subtypes of patients with HSA will result in improved outcomes.

    Study Details
  • Trial Evaluating an Investigational Agent for Management of Transitional Cell Carcinoma

    Currently Enrolling

    This trial is designed to evaluate the safety and preliminary pain management and anti-cancer effectiveness of a novel therapy in dogs with bladder transitional cell carcinoma (TCC).

    Study Details
The Oncology Service – Richmond
804-999-0001 | 5711 Staples Mill Road # 102 
  • Phone: 804-999-0001
  • Our Services
    • Medical Oncology
    • Radiation Oncology
    • Stereotactic Radiation Therapy
    • Diagnostic Imaging
  • For Your Pet
    • Client Registration Form
    • COVID Curb-Side Procedures
    • When Your Pet is a Patient
    • Your First Visit
    • Client Portal
    • FAQ
    • Pet Insurance
    • Grief Resources
    • Clinical Studies
  • For Veterinary Teams
    • COVID-19 Hospital Updates
    • Referral Forms and Portal
    • Continuing Education
    • Clinical Studies
  • About Us
    • Our Hospital
    • Our Team
    • Why Ethos
    • Contact Us
  • Blogs & Videos
    • Our Blogs
  • We’re Hiring!
    • Apply Today
    • Benefits and Perks
    • VetBloom
    • Continuing Education
© 2021 The Oncology Service – Richmond
Website Design by Jackrabbit